DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

about

Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.Identification of endothelial selectin as a potential prognostic marker in breast cancer.

P2860

Q42078197-A255A88C-A165-4E31-97E2-A6C400C26260 Q55360086-C1E7F9E8-DD6F-4165-9403-21BD9C6DB8AA

P2860

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

Item

http://www.wikidata.org/entity/Q42362638

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@en

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@nl

type

Item

label

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@en

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@nl

prefLabel

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@en

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@nl

P1476

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

@en

P2093

Alberto Ocaña

http://www.w3.org/2001/XMLSchema#string

Atanasio Pandiella

http://www.w3.org/2001/XMLSchema#string

Javier Pérez-Peña

http://www.w3.org/2001/XMLSchema#string

Raquel Páez

http://www.w3.org/2001/XMLSchema#string

Verónica Corrales-Sánchez

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the DNA Damage Response in Cancer

Repeated observation of breast tumor subtypes in independent gene expression data sets

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

Sequence analysis of mutations and translocations across breast cancer subtypes

Triple-negative breast cancer: clinical features and patterns of recurrence.

Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options.

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

Targeting Mitosis in Cancer: Emerging Strategies.

RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma.

P304

62834-62841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10886

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Alcaraz-Sanabria

Cristina Nieto-Jiménez

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28968952

http://www.w3.org/2001/XMLSchema#string

P921

DNA damage

P932

5609884

http://www.w3.org/2001/XMLSchema#string

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

about

P2860

P2860

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932